Fluvoxamine and Melatonin, a caution.
Fluvoxamine is a potent CYP1A2 inhibitor, and melatonin is metabolized almost entirely by CYP1A2. Coadministration raises melatonin AUC about 17-fold and peak concentration about 12-fold in healthy volunteers. The result is exaggerated, prolonged sedation, hangover effects the next day, and unpredictable shifts in sleep-wake timing.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Fluvoxamine and Melatonin
- Pair type
- Caution
- Evidence (highest tier)
- Strong
- Source citations
- 2 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Strong evidence
Caution
What is happening. Fluvoxamine is a potent CYP1A2 inhibitor, and melatonin is metabolized almost entirely by CYP1A2. Coadministration raises melatonin AUC about 17-fold and peak concentration about 12-fold in healthy volunteers. The result is exaggerated, prolonged sedation, hangover effects the next day, and unpredictable shifts in sleep-wake timing.
Mechanism. Fluvoxamine strongly inhibits hepatic CYP1A2, the enzyme responsible for the first metabolic step of melatonin (6-hydroxylation). Inhibition prevents first-pass and systemic clearance, producing a roughly 17-fold rise in melatonin AUC.
Recommendation. Avoid melatonin while on fluvoxamine. If a sleep aid is needed, talk to your prescriber about non-melatonin options. Even small melatonin doses (0.3-1 mg) can produce supratherapeutic blood levels in this combination.
Sources (2)
- Härtter S, Grözinger M, Weigmann H, Röschke J, Hiemke C. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther. 2000;67(1):1-6. PMID 10668847
- Grözinger M, Härtter S, Wang X, Röschke J, Hiemke C, Rose DM. Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile. Arch Gen Psychiatry. 2000;57(8):812-3. PMID 10920471
Stack Score
How this pair moves the number.
Effect on the composite score
If both Fluvoxamine and Melatonin are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.